The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Stem Cell Manufacturing Market Projected To Become By 2030 Based On Its 2026 Valuation?
The stem cell manufacturing market size has experienced significant expansion in recent years. This market is projected to expand from $19.17 billion in 2025 to $21.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. The historical growth of the market can be attributed to factors such as increasing clinical trials, approvals of stem cell therapies, investments in bioprocessing, the development of regulatory frameworks, and the expansion of contract manufacturing services.
The stem cell manufacturing market is projected to experience substantial growth in the coming years. This market is anticipated to expand to $33.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. The growth during the forecast period can be attributed to factors such as commercial-scale therapy production, advancements in cost reduction technologies, the emergence of decentralized manufacturing models, sophisticated cell expansion techniques, and regulatory harmonization. Key trends expected in the forecast period include the adoption of closed-system bioreactors, the development of scalable manufacturing platforms, increased automation of cell expansion processes, the implementation of quality-by-design processes, and optimized cryopreservation methods.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Stem Cell Manufacturing Market?
An increase in the elderly demographic is anticipated to drive the stem cell manufacturing market. The term “geriatric population” defines individuals aged 65 years and older. This demographic frequently experiences diverse ailments stemming from reduced immunity and advanced age. As people age, their susceptibility to chronic illnesses grows, and stem cell manufacturing offers a means to combat these conditions. For example, data from January 2024, provided by the Population Reference Bureau, a Kenya-based Nonprofit organization, indicates that the segment of Americans aged 65 and older is projected to expand from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Concurrently, this group’s proportion of the total population is expected to climb from 17% to 23% over the identical timeframe. Consequently, the expanding geriatric population is fostering the expansion of the stem cell manufacturing market.
What Segment Groups Are Identified Within The Stem Cell Manufacturing Market?
The stem cell manufacturing market covered in this report is segmented –
1) By Product: Consumables, Instruments, Stem Cell Lines
2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users
Subsegments:
1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits
2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers
3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)
Which Trends Are Shaping The Future Of The Stem Cell Manufacturing Market?
Major companies operating in the stem cell manufacturing market are concentrating on creating innovative offerings, such as GM-grade protein, to secure a competitive advantage in the sector. GM-grade protein is a classification given to protein powders and other related products that meet specific criteria for both quality and safety. For instance, in November 2023, ACROBiosystems Inc., a US-based supplier of recombinant proteins and other essential reagents, launched GM-grade DLL4 protein. This product is a recombinant, soluble version of Delta-like Ligand 4 (DLL4), which is a crucial signaling molecule vital for stem cell development and differentiation. The availability of GMP-grade DLL4 represents a significant milestone for advancing stem cell-based therapies, as it provides a high-quality, consistent, and scalable source of this important protein. DLL4 is recognized for promoting the self-renewal and expansion of hematopoietic stem cells (HSCs), which serve as precursors to all blood cells and can be utilized to supplement in vitro stem cell cultures, thereby enhancing the growth and differentiation of HSCs.
Which Companies Hold Significant Positions In The Stem Cell Manufacturing Market?
Major companies operating in the stem cell manufacturing market are Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group
Read the full stem cell manufacturing market report here:
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
Which Regions Are Projected To Dominate The Stem Cell Manufacturing Market In The Coming Years?
North America was the largest region in the stem cell manufacturing market in 2025. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Stem Cell Manufacturing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9402&type=smp
Browse Through More Reports Similar to the Global Stem Cell Manufacturing Market 2026, By The Business Research Company
Stem Cells Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Stem Cell Assay Global Market Report
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Induced Pluripotent Stem Cell Global Market Report
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model